End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,640 ARS | -1.22% |
|
+3.64% | +34.59% |
07-03 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
07-03 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
823B | ||||||
627B | ||||||
320B | ||||||
295B | ||||||
239B |